Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 69.9B | 58.5B | 53.5B |
Cost of revenue | — | 48.5B | 39.6B | 36.9B |
Gross profit | — | 21.4B | 18.9B | 16.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | — | 9.4B | 8.4B | 6.5B |
Non operating interest income | ||||
Income | — | 64M | 49M | 40M |
Expense | — | 62M | 58M | 57M |
Other income expense | — | — | — | — |
Pretax income | — | 11.0B | 7.8B | 7.2B |
Tax provision | — | 3.3B | 2.6B | 2.4B |
Net income | — | 7.7B | 5.2B | 4.8B |
Basic EPS | 159.3 | — | — | — |
Diluted EPS | 159.3 | — | — | — |
Basic average shares | 49.7M | — | — | — |
Diluted average shares | 49.7M | — | — | — |
EBITDA | — | 12.9B | 9.3B | 8.7B |
Net income from continuing op. | — | 11.0B | 7.8B | 7.2B |
Minority interests | — | -138M | -126M | -103M |
Preferred stock dividends | — | 0 | 0 | 0 |